Occudo Quantitative Strategies LP Acquires Shares of 12,113 DocuSign, Inc. (NASDAQ:DOCU)

Occudo Quantitative Strategies LP acquired a new stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 12,113 shares of the company's stock, valued at approximately $1,089,000.

A number of other hedge funds have also modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in DocuSign by 12.3% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 131,011 shares of the company's stock worth $11,786,000 after purchasing an additional 14,372 shares during the last quarter. Lazard Asset Management LLC grew its holdings in shares of DocuSign by 15.6% during the fourth quarter. Lazard Asset Management LLC now owns 185,853 shares of the company's stock worth $16,715,000 after buying an additional 25,038 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC acquired a new position in DocuSign in the 4th quarter valued at about $263,000. Janus Henderson Group PLC raised its stake in DocuSign by 13.1% during the 4th quarter. Janus Henderson Group PLC now owns 13,691 shares of the company's stock valued at $1,231,000 after acquiring an additional 1,581 shares during the last quarter. Finally, Focus Partners Wealth lifted its position in DocuSign by 19.8% during the 4th quarter. Focus Partners Wealth now owns 11,063 shares of the company's stock worth $995,000 after acquiring an additional 1,829 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

DocuSign Trading Up 2.1%

Shares of DOCU stock traded up $1.87 during trading hours on Friday, hitting $92.42. The company's stock had a trading volume of 2,010,367 shares, compared to its average volume of 2,753,903. The business has a fifty day moving average of $81.19 and a 200-day moving average of $85.09. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The stock has a market cap of $18.72 billion, a price-to-earnings ratio of 19.06, a P/E/G ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. DocuSign's revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.76 EPS. On average, equities analysts expect that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Bank of America lowered their price objective on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating on the stock in a research report on Friday, March 14th. William Blair restated an "outperform" rating on shares of DocuSign in a research report on Monday, April 21st. Royal Bank of Canada reiterated a "sector perform" rating and set a $90.00 target price on shares of DocuSign in a research report on Friday, March 14th. Robert W. Baird set a $93.00 price target on DocuSign in a research note on Friday, March 14th. Finally, Jefferies Financial Group cut their price objective on DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, March 31st. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, DocuSign has a consensus rating of "Hold" and an average price target of $92.46.

Insider Buying and Selling at DocuSign

In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the firm's stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total transaction of $608,720.00. Following the sale, the chief financial officer now owns 86,156 shares in the company, valued at $6,555,610.04. This trade represents a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now owns 8,270 shares in the company, valued at $722,880.70. This trade represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 47,851 shares of company stock worth $3,912,239. Corporate insiders own 1.66% of the company's stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.